Skip to content
OpenCapital
Get started

Unum UNM Cancer and Critical Illness Colonial — Premium Income

Other product segments

Group Long-term Disability
$603.6M-0.2%
Group Life
$572.4M+8.5%
Group Short-term Disability
$310.7M+11.6%
Voluntary Benefits
$253.8M+8.4%
Accident, Sickness, and Disability
$252.8M+2.3%
Long-term Care
$159.4M-9.5%
Individual Disability
$146.5M-13.2%
Life
$128.3M+7.0%
Dental and Vision
$82.3M+1.7%
Unum Poland
$54.6M+27.0%
Accidental Death & Dismemberment
$53M+10.0%
Supplemental
$50.3M+20.0%
Other Insurance Product Line
$34.7M-17.0%

Similar metrics at other companies

Aflac logo
AFLCancer — Gross premiums
$34.77B+4,044%
Aflac logo
AFLCritical care — Net premium income
$426M-1.8%
Aflac logo
AFLOther health — Net premium income
$385.5M-1.8%
Aflac logo
AFLCritical care — Gross premiums
$11.87B+2,590%
Aflac logo
AFLCancer — Liability for Future Policy Benefit, Expected Net Premium, Net Premium Collected
$314M-10.3%
Centene logo
CNCPremium and service revenues — Premium and service revenues
$44.66B+5.1%

Other financials

Income statement

See full
Revenue$3.4B+8.5%
Operating income$501.8M+2.4%
Net income$232.0M+22.7%
EPS (diluted)$1.41+33.0%

Balance sheet

See full
Cash & equivalents$192.6M-19.0%
Total debt$3.8B+0.5%
Total equity$10.9B-2.9%
Total assets$62.7B+0.4%

Cash flow

See full
Operating cash flow$340.8M-3.6%
CapEx$39.6M+10.6%
Free cash flow$301.2M-5.2%

Valuation

See full
Market cap$14.38B-17.0%
Enterprise value$17.95B-13.3%
P/E18.4×+7.4×
P/S1.1×-0.3×

Profitability

See full
Net margin5.9%-6.5pp
FCF margin11.2%+1.4pp

Returns & leverage

See full
Return on equity7.1%-7.6pp
Debt / equity0.3×0.0×

Where this comes from

Reported directly by Unum in its filing.

Tagged under the XBRL concept us-gaap:PremiumsEarnedNet.

The official record: Unum’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Unum's cancer and critical illness colonial — premium income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Unum's cancer and critical illness colonial — premium income?
Unum (UNM) reported cancer and critical illness colonial — premium income of $91.6M in Q1 2026.
How has Unum's cancer and critical illness colonial — premium income changed year-over-year?
Unum's cancer and critical illness colonial — premium income increased by 1.4% year-over-year, from $90.3M to $91.6M.
What is the long-term trend for Unum's cancer and critical illness colonial — premium income?
Over 4 years (2021 to 2025), Unum's cancer and critical illness colonial — premium income has grown at a 0.7% compound annual growth rate (CAGR), from $352.2M to $362M.
What does cancer and critical illness colonial — premium income mean?
The total revenue earned from cancer and critical illness insurance policies within the Colonial Life segment.
How do you interpret cancer and critical illness colonial — premium income?
An increase suggests successful sales growth or higher policy retention, while a decrease may indicate competitive pressure or reduced demand for supplemental health coverage.
How does cancer and critical illness colonial — premium income compare across companies?
Comparable to supplemental health insurance premium revenue at other life and health insurance providers, often benchmarked against industry-wide growth rates for voluntary benefits.